BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jülicher P, Chulanov VP, Pimenov NN, Chirkova E, Yankina A, Galli C. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis. PLoS One 2019;14:e0219687. [PMID: 31310636 DOI: 10.1371/journal.pone.0219687] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Kobyakova OS, Starodubov VI, Khaltourina DA, Zykov VA, Zubkova TS, Zamiatnina ES. Promising measures to reduce the mortality in Russia: an analytical review. Zdravoohran Ross Fed 2021;65:573-580. [DOI: 10.47470/0044-197x-2021-65-6-573-580] [Reference Citation Analysis]
2 Marcellusi A, Mennini FS, Ruf M, Galli C, Aghemo A, Brunetto MR, Babudieri S, Craxi A, Andreoni M, Kondili LA. Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation. Liver Int 2021. [PMID: 34582627 DOI: 10.1111/liv.15070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Corcorran MA, Ludwig-Baron N, Cheng DM, Lioznov D, Gnatienko N, Patts G, So-Armah K, Blokhina E, Bendiks S, Krupitsky E, Samet JH, Tsui JI. The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia. AIDS Behav 2021;25:2533-41. [PMID: 33730255 DOI: 10.1007/s10461-021-03214-y] [Reference Citation Analysis]
4 Jülicher P, O'Kane M, Price CP, Christenson R, John AS. Health economic evaluations of medical tests: Translating laboratory information into value - A case study example. Ann Clin Biochem 2021;:45632211013852. [PMID: 33874738 DOI: 10.1177/00045632211013852] [Reference Citation Analysis]
5 Giusepi I, John AS, Jülicher P. Who Conducts Health Economic Evaluations of Laboratory Tests? A Scoping Review. The Journal of Applied Laboratory Medicine 2020;5:954-66. [DOI: 10.1093/jalm/jfaa107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pollock KG, McDonald SA, Gunson R, McLeod A, Went A, Goldberg DJ, Hutchinson SJ, Barclay ST. Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype. J Viral Hepat 2020;27:996-1002. [PMID: 32479681 DOI: 10.1111/jvh.13337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Mate-Cano I, Alvaro-Meca A, Ryan P, Resino S, Briz V. Epidemiological trend of hepatitis C-related liver events in Spain (2000-2015): A nationwide population-based study. Eur J Intern Med 2020;75:84-92. [PMID: 32143898 DOI: 10.1016/j.ejim.2020.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Optimising hepatitis C screening by use of HCV antigen test. PharmacoEcon Outcomes News 2019;833:26-26. [DOI: 10.1007/s40274-019-6090-4] [Reference Citation Analysis]